Streetbeat News

Regulatory

VRTX

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced positive results from its Phase 3 trials of the vanzacaftor/tezacaftor/deutivacaftor (vanza triple) treatment for cystic fibrosis, showing non-inferiority to Trikafta and superiority in reducing sweat chloride levels. The company also reported Q4 2023 adjusted EPS of $4.20, beating consensus, with sales of $2.52 billion. Vertex expects FY 2024 sales of $10.55 billion-$10.75 billion and plans to submit new drug applications by mid-2024.

Portfolio Pulse from Vandana Singh

February 06, 2024 | 2:57 pm

BA

SPY

The U.S. National Transportation Safety Board (NTSB) is set to release a preliminary report on Tuesday regarding a cabin emergency incident involving a Boeing 737 Max 9. The incident has drawn significant attention, and the forthcoming report is anticipated to shed light on the circumstances surrounding the event.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:37 pm

TENX

Tenax Therapeutics' shares surged following the announcement that the USPTO has granted a notice of allowance for its U.S. patent application for Levosimendan, aimed at treating Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:34 pm

FBLG

FibroBiologics has been granted three Japanese patents related to enhancing fibroblast therapeutic activity, augmenting fibroblasts regenerative activity, and the interaction of fibroblasts and immune cells for activation. These patents, invented by Pete O'Heeron, could significantly advance FibroBiologics' position in regenerative medicine and therapeutic applications.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:32 pm

MULN

Mullen Automotive's majority-owned subsidiary, Bollinger Motors, has received approval from the IRS for a $40,000 commercial EV tax credit. This approval could significantly enhance the attractiveness of Bollinger's electric vehicles (EVs) for commercial buyers, potentially boosting sales and impacting Mullen Automotive's financial outlook positively.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:23 pm

ZYXI

Zynex, Inc. (NASDAQ:ZYXI) announced FDA clearance for its next-generation M-Wave Neuromuscular Electrical Stimulation device, designed for pain management, rehabilitation, and enhancing exercise performance. The M-Wave, which replaces the E-Wave, offers a more intuitive design and additional functionality, aiming for broader adoption in both clinical and home settings.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:16 pm

ZYXI

Zynex, Inc. has received FDA clearance for its M-Wave neuromuscular electrical stimulation device, a significant milestone that could enhance the company's product portfolio and market position.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:16 pm

VTRS

The UK's Competition and Markets Authority (CMA) has initiated a merger inquiry into Theramex and Viatris, as reported by Reuters. This investigation will assess the potential impacts of the merger on competition within the UK market.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:13 pm

WHR

South Africa's Competition Tribunal has conditionally approved the merger between Beko Europe BV and Whirlpool Corporation's MDA business in Morocco and the UAE. The approval is a significant step towards finalizing the deal, which could have implications for Whirlpool's operations and strategic positioning in these regions.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 2:10 pm

DELL

INTC

LNVGF

Lenovo's shares plummeted nearly 10% following a Newsweek article citing China Tech Threat's advice to ban Lenovo PCs in the U.S. due to espionage risks. This has raised concerns about Lenovo's future in its largest market, North America, which accounts for 36% of its revenue. Additionally, Intel's lower-than-expected revenue forecast has sparked fears of a PC demand slowdown, potentially impacting Lenovo. There's speculation that Dell, a major rival and financial backer of China Tech Threat, might be influencing these developments to harm Lenovo.

Portfolio Pulse from The Bamboo Works

February 06, 2024 | 2:03 pm